Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer.
about
Neuroendocrine differentiation in prostate cancerNeuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinaseInterleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancer.Suppression of neurotensin receptor type 1 expression and function by histone deacetylase inhibitors in human colorectal cancers.Autocrine and paracrine signaling through neuropeptide receptors in human cancer.Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation.Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapyRegulation of the neurotensin NT(1) receptor in the developing rat brain following chronic treatment with the antagonist SR 48692Next revolution in molecular theranostics: personalized medicine for urologic cancers.Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma.TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation.Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.Oncogenic role of neurotensin and neurotensin receptors in various cancers.Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(IV)-peptide bioconjugates.Synthesis and cytotoxicity of a bimetallic ruthenocene dicobalt-hexacarbonyl alkyne peptide bioconjugate.Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.Bioenergetics of rat prostate cancer cell migration.Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations.Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24.VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal.Developmental dynamics of neurotensin binding sites in the human hypothalamus during the first postnatal year.An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines.Evidence for neurotensin autoreceptors and relationship of neurotensin and its receptors with tyrosine hydroxylase-positive neurons in rat primary hypothalamic cultures.
P2860
Q24657547-0AC6A8EA-4AAA-4B12-8811-D8432DE86635Q24746249-A866BC37-CFCD-4F25-9C53-93D14B5002F7Q24746259-70AF6D52-8992-4E7B-825D-7F27ED16C540Q30441092-8144859E-FE2A-43CE-AB7C-92589112600FQ33853729-93A08A96-7098-430A-8838-701A9CFB1CBEQ34100964-D922076D-15E8-4CEA-AC1C-19951D9D156BQ34225976-E56186DD-F865-4058-A9BD-2D684285ABEEQ34286857-A077491B-7CFC-4F12-B93C-E7F419AC71B9Q36540348-6DFADEB3-7B7B-4DA9-A338-A407CF763CF1Q36915456-5B3B4846-77C3-445D-9ABC-B15038EFBD9CQ38559336-88C7EA3A-9D74-4CC2-B2ED-E91981883EF1Q38680000-CC7830FB-F1AF-48F8-BEE1-7BA9F3624D81Q38952586-6A4CEC4C-0191-44E9-BAE2-7118CC314C9BQ39041611-9B063BB6-DB0C-4630-8848-DFC917177D26Q39337728-88743131-C5CC-4AC3-9351-0B7DA48D121BQ39400663-542E9103-536B-4D1B-81BF-6BB29CA8349AQ39616731-4463FF55-D9A1-4746-830A-C646CD2BE8AFQ40736037-A6E93CAD-AC46-429B-8EF4-53060592BB68Q41065077-62E57792-E13B-4202-8F01-6F0C5176D28FQ41110192-E545E12D-6ABD-4E2D-A276-29F008C45F72Q41150864-F42B45B8-BCD3-4B97-B4A0-80B9EBD2BA34Q42162928-253480ED-FC47-48EA-9186-C62EAEEC0F18Q42872100-F418808F-C4F7-46DB-9931-8DBD3039EC2FQ43176313-BF3AA7E3-6996-46F2-B85B-89B3848AF1F5Q43576645-D7DCA8DF-487C-497F-B33F-E27EAE8280B0Q48669013-77451806-A86F-437A-A3BA-D6CC38A92D6F
P2860
Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Neurotensin is an autocrine tr ...... awal in human prostate cancer.
@ast
Neurotensin is an autocrine tr ...... awal in human prostate cancer.
@en
type
label
Neurotensin is an autocrine tr ...... awal in human prostate cancer.
@ast
Neurotensin is an autocrine tr ...... awal in human prostate cancer.
@en
prefLabel
Neurotensin is an autocrine tr ...... awal in human prostate cancer.
@ast
Neurotensin is an autocrine tr ...... awal in human prostate cancer.
@en
P2093
P2860
P356
P1476
Neurotensin is an autocrine tr ...... awal in human prostate cancer.
@en
P2093
P2860
P304
P356
10.1073/PNAS.91.11.4673
P407
P577
1994-05-01T00:00:00Z